A new drug on the market is claimed by its manufacturers to reduce overweight women by 4.55 kg per month with a standard deviation of 0.91 kg. Forty women chosen at random have reported losing an average of 4.05 kg within a month.
1. The following null and alternative hypotheses need to be tested:
"H_0:\\mu=4.55"
"H_a:\\mu\\not=4.55"
This corresponds to a two-tailed test, for which a z-test for one mean, with known population standard deviation will be used.
2. Based on the information provided, the significance level is "\\alpha = 0.05," and the critical value for a two-tailed test is"z_c = 1.96."
The rejection region for this two-tailed test is "R = \\{z: |z| > 1.96\\}."
3. The z-statistic is computed as follows:
4. Since it is observed that "|z| = 3.475 > 1.96=z_c," it is then concluded that the null hypothesis is rejected.
Using the P-value approach:
The p-value is "p=2P(Z<-3.475)=0.000511," and since "p=0.000511<0.05=\\alpha," it is concluded that the null hypothesis is rejected.
5. Therefore, there is enough evidence to claim that the population mean "\\mu"
is different than 4.55, at the "\\alpha = 0.05" significance level.
Comments
Leave a comment